Fundamental analysis of $BCTXZ (BriaCell Therapeutics Corp.) based on financial data and reported results.

#BCTXZ #BriaCell

BriaCell Plunges After Pricing $30M Public Offering; Shares Slide Sharply Pre-Market BriaCell Therapeutics Corp. (Nasdaq: BCTX / BCTXL) saw its stock slump over 50 % in early trading after announcing the pricing of a $30 million underwritten pub

#BriaCell #BCTX Plunges After Pricing $30M Public Offering; Shares Slide Sharply Pre-Market
prismmarketview.com/briacel...

BriaCell Therapeutics stock tumbles after announcing public offering Investing.com -- BriaCell Therapeutics Corp (NASDAQ:BCTX) stock plunged 22% following the announcement of a public offering that could significantly dilute existing shareholders. The clinical-stage biotechnology company revealed plans to offer up to 6,825,938 common units on a best efforts basis. Each unit, priced at $2.93, consists of one common share and one warrant to purchase an additional common share at an exercise price of $5.25, with the warrants set to expire on April 28, 2030. BriaCell is also offering pre-funded units as an alternative for purchasers whose acquisition would result in them owning more than 4.99% (or optionally 9.99%) of the company’s outstanding shares. These pre-funded units include a pre-funded warrant exercisable at $0.001 per share and one regular warrant, with the purchase price being $0.001 less than the common unit price. The significant stock decline reflects investor concerns about potential share dilution. While the offering will provide capital for the company’s operations, the issuance of new shares and potential future exercise of warrants could substantially increase the number of outstanding shares. The components of both the common units and pre-funded units will be immediately separable upon issuance and will trade separately. The offering comes as BriaCell continues development of its immunotherapy candidates for cancer treatment. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Before you buy stock in BCT, consider this: ProPicks AI are 6 easy-to-follow model portfolios created by Investing.com for building wealth by identifying winning stocks and letting them run. Over 150,000 paying members trust ProPicks to find new stocks to buy – driven by AI. The ProPicks AI algorithm has just identified the best stocks for investors to buy now. The stocks that made the cut could produce enormous returns in the coming years. Is BCT one of them?

Click Subscribe #BriaCell #Biotech #Investing #StockMarket #PublicOffering

Click Subscribe #BriaCell #Therapeutics #StockMarket #LungCancer #Metastasis